North America Travel Vaccines Market Report 2025-2033 Combination Vaccines, Rising Patient Awareness And The Need For Epidemic Prevention Bolster Growth

(MENAFN- GlobeNewsWire - Nasdaq) The North America travel vaccines market presents opportunities driven by increasing travel, government mandates, and advanced technologies like combination vaccines. Rising patient awareness and the need for epidemic prevention will further propel demand. Key regions include the US, Canada, and Mexico.

Dublin, Sept. 12, 2025 (GLOBE NEWSWIRE) -- The "North America Travel Vaccines Market Report by Composition, and Country 2025-2033" report has been added to ResearchAndMarkets's offering.
The North America travel vaccines market size reached USD 2.01 Billion in 2024. Looking forward, the publisher expects the market to reach USD 3.24 Billion by 2033, exhibiting a growth rate (CAGR) of 5.5% during 2025-2033.

North America travel vaccines market is currently being driven by several factors. One of the key factors driving the demand of travel vaccines is their ability to prevent the risk of disease epidemic. Moreover, vaccination provides immunity to individuals, travelling to places where there is a high risk of exposure or contracting a specific disease.

As a result, governments in the region have mandated vaccination before visiting certain destinations with a high prevalence of infectious diseases. Other factors driving the demand of travel vaccines in the region include rising number of travelers, government initiatives, technological advancements such as combination vaccines and needle free techniques, etc.

Key Questions Answered in This Report

• What was the size of the North America travel vaccines market in 2024?
• What is the expected growth rate of the North America travel vaccines market during 2025-2033?
• What are the key factors driving the North America travel vaccines market?
• What has been the impact of COVID-19 on the North America travel vaccines market?
• What is the breakup of the North America travel vaccines market based on the composition?
• What is the breakup of the North America travel vaccines market based on the disease?
• What are the key regions in the North America travel vaccines market?

Key Attributes:

Report Attribute	Details
No. of Pages	123
Forecast Period	2024 - 2033
Estimated Market Value (USD) in 2024	$2.01 Billion
Forecasted Market Value (USD) by 2033	$3.24 Billion
Compound Annual Growth Rate	5.4%
Regions Covered	North America

Key Market Segmentation:

Key Regions

• United States
• Canada
• Mexico
• Analysis for Each Country

Market by Composition

• Mono Vaccines
• Combination Vaccines

Market by Disease

• Hepatitis A
• DPT
• Yellow Fever
• Typhoid
• Hepatitis B
• Measles and Mumps
• Rabies
• Meningococcal
• Varicella
• Japanese Encephalitis
• Others

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• North American Travel Vaccines Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN12092025004107003653ID1110053072